Management of relapsed-refractory diffuse large B cell lymphoma

Management of relapsed-refractory diffuse large B cell lymphoma

Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR DLBCL), which accounts for approximately one-third of patients with DLBCL, remains a major cause of morbidity and mortality. Managing RR DLBCL continues to be a challenge to the treating hemato-oncologist. Salvage high-dose chemotherapy followed...

Full description

Bibliographic Details
Main Authors: Lalit S Raut, Prantar P Chakrabarti
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2014-01-01
Series:South Asian Journal of Cancer
Subjects:
Activated B cell
autologous stem cell transplant
diffuse large B cell lymphoma
germinal center B
high dose chemotherapy
relapsed refractory
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2014;volume=3;issue=1;spage=66;epage=70;aulast=Raut

Internet

http://journal.sajc.org/article.asp?issn=2278-330X;year=2014;volume=3;issue=1;spage=66;epage=70;aulast=Raut

Similar Items